European Patent Office

T 0289/91 (ACE inhibitors) du 10.03.1993

Identifiant européen de la jurisprudence
ECLI:EP:BA:1993:T028991.19930310
Date de la décision
10 mars 1993
Numéro de l'affaire
T 0289/91
En ligne le
25 juin 1993
Requête en révision de
-
Numéro de la demande
82110070.8
Classe de la CIB
C07D 209/52
Langue de la procédure
Allemand
Distribution
Publiées au Journal officiel de l'OEB (A)
Téléchargement
-
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Derivate der cis, endo-2-Azabicyclo-(3.3.0)-octan-3- carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
Nom du demandeur
Hoechst
Nom de l'opposant
Knappwost
Adolf
Chambre
3.3.01
Sommaire

1. The admissibility of the opposition is an indispensable procedural requirement for the substantive examination of the opposition submissions at every stage of the proceedings, i.e. also in appeal proceedings, and, as such, it must be examined by the EPO of its own motion (point 2.1 of the Reasons).

2. A statutory declaration that the opponent is acting on his own behalf may only be required if there are concrete grounds for casting serious doubt on the opponent's true identity. Serious doubts as to the opponent's true identity are not justified by the mere fact that the opponent does not have any obvious personal or economic interest in the subject-matter of the patent (following T 635/88, OJ EPO 1993, 608, point 2.2 of the Reasons).

Mots-clés
Admissibility of opposition contested for first time during appeal proceedings
Entitlement to file opposition (yes)
Application for investigation to determine true identity of opponent rejected
Novelty (yes, selection)
Inventive step (yes)
Establishing closest prior art
Exergue
-
Affaires citées
-

ORDER

For these reasons it is decided that:

1. The main request is refused.

2. ...